Amorphous Solid Dispersion Particles

Comparing Co-precipitation, Resonant Acoustic Mixing, and Spray-drying Techniques

4K microstructure render of a DigiM pharmaceutical sample showing internal phase composition at high resolution
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network

The use of the amorphous phase of compounds has become the primary method of choice for overcoming oral bioavailability problems related to poorly soluble drugs. Due to the unstable nature of the amorphous material, the preparation method can have a profound impact on the morphology and mechanical properties of the amorphous solid dispersion (ASD) intermediate.

DigiM evaluation of amorphous solid dispersion particle morphology

In order to understand the impact of method of preparation, this study explores the effect of co-precipitation and spray drying methods on the morphology and mechanical properties of amorphous solid dispersion powders. The effectiveness of resonant acoustic mixing (RAM), a new technology, to generate co-precipitated ASDs was also studied. Focused ion beam scanning electron microscopy (FIB-SEM) was utilized to study particle morphology and internal porosity for particles generated from spray drying and resonant acoustic mixing. Porosity characteristics were successfully correlated with tableting compaction and tensile strength.

AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Our Expertise

In Numbers

95
+
%

Programs Supported

981
+
%

Formulations Digitized

22
+
%

Pharmaceutical Partners

Stats section background image for DigiM Solution website showing pharmaceutical data visualization context

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Purple tablet dispersing into a fine particle cloud, illustrating drug microstructure disintegration